Schonfeld Strategic Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
+10,340
| New | +$237K | ﹤0.01% | 1652 |
|
|
2025
Q1 | – | Sell |
-42,614
| Closed | -$1.58M | – | 2054 |
|
|
2024
Q4 | $1.58M | Buy |
42,614
+33,007
| +344% | +$1.23M | 0.01% | 871 |
|
|
2024
Q3 | $466K | Sell |
9,607
-2,143
| -18% | -$104K | ﹤0.01% | 1332 |
|
|
2024
Q2 | $470K | Buy |
11,750
+5,521
| +89% | +$221K | ﹤0.01% | 1381 |
|
|
2024
Q1 | $274K | Buy |
+6,229
| New | +$274K | ﹤0.01% | 1501 |
|
|
2023
Q1 | – | Sell |
-16,398
| Closed | -$459K | – | 1979 |
|
|
2022
Q4 | $459K | Sell |
16,398
-16,502
| -50% | -$462K | ﹤0.01% | 1556 |
|
|
2022
Q3 | $924K | Buy |
32,900
+25,100
| +322% | +$705K | 0.01% | 1307 |
|
|
2022
Q2 | $271K | Sell |
7,800
-14,700
| -65% | -$511K | ﹤0.01% | 1654 |
|
|
2022
Q1 | $807K | Buy |
+22,500
| New | +$807K | 0.01% | 1040 |
|
|
2020
Q1 | – | Sell |
-70,179
| Closed | -$1.35M | – | 1117 |
|
|
2019
Q4 | $1.35M | Buy |
+70,179
| New | +$1.35M | 0.03% | 423 |
|
|
2019
Q3 | – | Sell |
-17,000
| Closed | -$358K | – | 988 |
|
|
2019
Q2 | $358K | Sell |
17,000
-26,500
| -61% | -$558K | 0.01% | 729 |
|
|
2019
Q1 | $888K | Buy |
+43,500
| New | +$888K | 0.03% | 534 |
|
|
2017
Q1 | – | Sell |
-25,561
| Closed | -$470K | – | 584 |
|
|
2016
Q4 | $470K | Buy |
+25,561
| New | +$470K | 0.06% | 349 |
|